TipRanks
Go Ultimate55% OFF

Compare Aroa Biosurgery Ltd (ARX) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:ARXAroa Biosurgery LtdAUD 0.55AUD 190.25M45.83-28.10%Moderate BuyUnlock the AU:ARX analyst price target with TipRanks PremiumAU:ARXUnlock the AU:ARX top-analyst price target with TipRanks Premium
AU:PNVPolynovo AUD 0.91AUD 625.21M85.38-34.18%Strong BuyUnlock the AU:PNV analyst price target with TipRanks PremiumAU:ARX vs AU:PNVUnlock the AU:PNV top-analyst price target with TipRanks Premium
AU:COHCochlear AUD 143.64AUD 9.39B63.84-49.67%NeutralUnlock the AU:COH analyst price target with TipRanks PremiumAU:ARX vs AU:COHUnlock the AU:COH top-analyst price target with TipRanks Premium
AU:IPDImpedimed LimitedAUD 0.01AUD 14.66M-0.34-64.10%Moderate BuyUnlock the AU:IPD analyst price target with TipRanks PremiumAU:ARX vs AU:IPDUnlock the AU:IPD top-analyst price target with TipRanks Premium
AU:OSLOncoSil Medical LtdAUD 0.68AUD 24.96M-1.42-49.33%―Unlock the AU:OSL analyst price target with TipRanks PremiumAU:ARX vs AU:OSLUnlock the AU:OSL top-analyst price target with TipRanks Premium
AU:EBREBR Systems, Inc. Shs Chess Depository Interests Repr 1 ShAUD 0.13AUD 97.93M-0.94-88.48%Strong BuyUnlock the AU:EBR analyst price target with TipRanks PremiumAU:ARX vs AU:EBRUnlock the AU:EBR top-analyst price target with TipRanks Premium

Performance Comparison

-100%-75%-50%-25%0%25%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:ARXAroa Biosurgery Ltd0.55-0.24-30.82%
AU:PNVPolynovo 0.91-0.36-28.46%
AU:COHCochlear 143.64-133.99-48.26%
AU:IPDImpedimed Limited0.01-0.02-62.16%
AU:OSLOncoSil Medical Ltd0.68-0.58-46.12%
AU:EBREBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh0.13-0.98-88.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts